Effect of Panel-Reactive Antibody in Predicting Crossmatch Selection of Cadaveric Kidney Recipients

Transplantation Proceedings

Volumn 39, Issue 2, 2007, Pages 429-431

  Lieber, S R ^a   Perez, F V T ^a   Tabossi, M R ^a   Persoli, L B L ^a   Marques, S B D ^a   Mazzali, M ^a   Alves Filho, G ^a   de Souza, C A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DITHIOTHREITOL; HLA ANTIBODY; IMMUNOGLOBULIN G; PANEL REACTIVE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SCREENING; ARTICLE; BLOOD SAMPLING; CADAVER; CHRONIC KIDNEY FAILURE; COMPLEMENT DEPENDENT CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; SENSITIZATION; T LYMPHOCYTE;

ABO BLOOD-GROUP SYSTEM; CADAVER; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; T-LYMPHOCYTES; TISSUE DONORS; WAITING LISTS;

EID: 33847711070     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.01.045     Document Type: Article

References (17)

1. Lietz K., Lao M., Paczek L., et al. The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. Ann Transplant 8 (2003) 17
2. Opelz G., Wujciak T., Dohler B., et al. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1 (1999) 344
3. Arias M. Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 35 (2003) 1655
4. Zachary A.A., Klingman L., Thome N., et al. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation 60 (1995) 498
5. Lieber S.R., Beck S.T., Persoli L.B., et al. Standardization of cellular immunoenzyme assay for anti-HLA class I antibodies evaluation: comparison with complement-dependent cytotoxicity methods. Transplant Proc 31 (1999) 2989
6. Worthington J.E., Thomas A.A., Dyer P.A., et al. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome. Transplantation 65 (1998) 121
7. Pei R., Wang G., Tarsitani C., et al. Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol 59 (1998) 313
8. Gibney E.M., Cagle L.R., Freed B., et al. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 21 (2006) 2625
9. Speiser D.E., and Jeannet M. Renal transplantation to sensitized patients: decreased graft survival probability associated with a positive historical crossmatch. Transpl Immunol 3 (1995) 330
10. Singh D., Kiberd B.A., West K.A., et al. Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients. Transplant Proc 35 (2003) 2395
11. Michelon T., Schroeder R., Fagundes I., et al. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation. Transplant Proc 37 (2005) 2750
12. Schonemann C., Groth J., Leverenz S., et al. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance. Transplantation 65 (1998) 1519
13. Uboldi d.C.M., Pratico L., and Curtoni E.S. Comparison of different techniques for detection of anti-HLA antibodies in sera from patients awaiting kidney transplantation. Eur J Immunogenet 29 (2002) 379
14. Slavcev A., Lacha J., Honsova E., et al. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test. Ann Transplant 9 (2004) 44
15. Arnold M.L., Zacher T., Dechant M., et al. Detection and specification of noncomplement binding anti-HLA alloantibodies. Hum Immunol 65 (2004) 1288
16. Bryan C.F., Martinez J., Muruve N., et al. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype. Clin Transplant 15 (2001) 28
17. Opelz G. Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365 (2005) 1570